Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RO-7 is a next-generation polymerase (PA) endonuclease influenza A and B viruses inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,970.00 | |
50 mg | 8-10 weeks | $ 2,580.00 | |
100 mg | 8-10 weeks | $ 3,400.00 |
Description | RO-7 is a next-generation polymerase (PA) endonuclease influenza A and B viruses inhibitor. |
In vitro | RO-7 is a potently inhibits influenza virus replication and belongs to a new class of drugs in late-stage clinical trials with treatment of influenza virus infection, with anti-influenza activity in vitro and protects mice from lethal challenge with both influenza A and B viruses. |
In vivo | RO-7 keeps mice from lethal challenge with both influenza A and B viruses. |
Molecular Weight | 487.49 |
Formula | C24H20F3N3O3S |
CAS No. | 1370241-45-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RO-7 1370241-45-4 Others RO 7 RO7 inhibitor inhibit